Environmental and genetic risk factors and gene-environmental interactions in the pathogenesis of chronic obstructive lung disease

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 4, 2000, Pages 733-742

  Walter, R ^a   Gottlieb, D J ^a   O'Connor, G T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Air pollution; Alpha 1 antitrypsin; Environment; Genetics; Lung disease; Obstructive; Occupational diseases

Indexed keywords

ALCOHOL; ALPHA 1 ANTITRYPSIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CHLORINE; ELASTASE; FISH OIL; HYDROGEN SULFIDE; METHACRYLIC ACID METHYL ESTER; NITROGEN DIOXIDE; OZONE; POLYVINYLCHLORIDE; RETINOL; SILICON DIOXIDE; STYRENE; SULFUR DIOXIDE; TOBACCO SMOKE;

AIR POLLUTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIET; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME INHIBITION; FUME; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC RISK; GRAIN DUST; HERITABILITY; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG PARENCHYMA; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

NICOTIANA TABACUM;

EID: 0033835663     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s4733     Document Type: Article

References (232)

1. Trends in COPD mortality in the United States
2. Incidence prevalence and mortality: Intra- and inter-county differences
3. Position paper of the American Association of Cardiovascular and Pulmonary Rehabilitation: Scientific basis of pulmonary rehabilitation
4. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
5. Predicting 15-year chronic bronchitis mortality in the Whitehall Study
6. Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular mortality among men in England, Scotland, and the United States
7. The beginnings of chronic airflow limitation
8. Anonymous. Effect of cigarette smoke exposure on measures of chronic obstructive lung disease morbidity
9. Chronic bronchitis and emphysema
10. Contribution of emphysema and small airways in COPD
11. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease
12. Relation between small airways disease and parenchymal destruction in surgical lung specimens
13. Radial traction and small airways disease in excised human lungs
14. The biochemical pathogenesis of chronic obstructive pulmonary disease: Protease-antiprotease imbalance in emphysema and diseases of the airways
15. Twelve years spirometric changes among Paris area workers
16. Longitudinal changes in forced expiratory volume in one second in adults, effects of smoking and smoking cessation
17. Effects of multiple attempts to quit smoking and relapses on pulmonary function
18. The natural history of forced expiratory volume: Effects of cigarette smoking and respiratory symptoms
19. Pathologic changes in the peripheral airways of young cigarette smokers
20. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation
21. The diagnosis of emphysema: A computed tomographic-pathologic correlation
22. The development of large and small airways
23. Structure of central airways in current smokers and ex-smokers with and without mucus hypersecretion: Relationship to lung function
24. The fate of neutrophil elastase incorporated by human alveolar macrophages
25. Cigarette smoking and lung destruction
26. Cellularity of the alveolar walls in smokers and its relation to alveolar destruction
27. Lung phagocyte recruitment and metabolic alterations induced by cigarette smoking in humans and hamsters
28. The relationship of peripheral leukocyte count and cigarette smoking to pulmonary function among adult men
29. Risk factors for ventilatory impairment among middle-aged and elderly men: The normative aging study
30. Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidemiology
31. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers
32. Demonstration of a free elastolytic metalloenzyme in human lung lavage fluid and its relationship to alpha 1-antiprotease
33. The antielastase screen of the lower respiratory tract of alpha 1-proteinase inhibitor-sufficient patients with emphysema or pneumothorax
34. Specificity and sensitivity of the assay for elastin-derived peptides in chronic obstructive pulmonary disease
35. Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with chronic obstructive pulmonary disease
36. Putative role of neutrophil elastase in the pathogenesis of emphysema
37. The role of proteinases in the pathogenesis of chronic bronchitis
38. The role of neutrophil elastase in chronic inflammation
39. Urinary desmosine excretion in smokers with and without rapid decline of lung function: The Normative Aging Study
40. Lankhorst I. Oxidative Stress in chronic obstructive pulmonary disease
41. Anonymous. The physicochemical and toxicological studies of environmental tobacco smoke
42. Attenuation of the oxidant/ antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease
43. Systemic oxidative stress in asthma. COPD, and smokers
44. Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease
45. Anonymous. Health effects of environmental tobacco smoke exposure
46. Indoor air pollution and its effect on pulmonary function of adult non-smoking women. III: Passive smoking and pulmonary function
47. Longitudinal study of the effects of maternal smoking on pulmonary function in children
48. Anonymous. Effects of exposure to environmental tobacco smoke on lung function and respiratory symptoms
49. Longitudinal studies of active and passive smoking
50. Smoking and other risk factors
51. Focus on grain dust and health
52. Grain dust and lung function. Dose-response relationships
53. Airway size and the rate of pulmonary function decline in grain handlers
54. Epidemiologic study of clinical and physiologic parameters in grain handlers of Northern United States
55. Epidemiologic health survey of grain elevator workers in British Columbia
56. Chronic bronchitis and decreased forced expiratory flow rates in lifetime nonsmoking grain workers
57. Respiratory abnormalities among grain handlers: A clinical, physiologic, and immunologic study
58. 1 in grain handlers. Relation to level of dust exposure
59. Documentation of ill-health effects of occupational exposure to grain dust through sequential, coherent epidemiologic investigation
60. Does seasonal employment in grain elevators increase nonspecific airways responsiveness?
61. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan
62. Variables of pulmonary allergy and inflammation in grain elevator workers
63. Cotton dust and endotoxin exposure and long-term decline in lung function: Results of a longitudinal study
64. A survey of respiratory disease in cotton operatives
65. Respiratory symptoms and pulmonary function of workers exposed to cork dust, toluene diisocyanate and conidia
66. Respiratory diseases in wood workers
67. Airflow obstruction in chalkpowder and sugar workers
68. Health effects of working in pulp and paper mills: Exposure, obstructive airways disease, hypersensitivity reactions, and cardiovascular diseases
69. Coal mining and chronic obstructive pulmonary disease: A review of the evidence
70. Mortality of Dutch coal miners in relation to pneumoconiosis, chronic obstructive pulmonary disease, and lung function
71. The predictors of emphysema in South African gold miners
72. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence
73. Emphysema and airway obstruction in non-smoking South African gold miners with long exposure to silica dust
74. Studies of respiratory morbidity in rubber workers. Part IV: Respiratory morbidity in talc workers
75. Pulmonary function and peripheral airway disease in patients with mineral dust or fume exposure
76. Change in obstructive pulmonary function as a result of cumulative exposure to welding fumes as determined by magnetopneumography in Japanese arc welders
77. 1 and airflow limitation related to occupational exposures in men of an urban community
78. Occupational exposure to dust and lung disease among sheet metal workers
79. Small airways dysfunction among non-smoking shipyard arc welders
80. Pulmonary functional impairment from years of arc welding
81. A thirteen-year follow-up of respiratory effects of acute exposure to sulfur dioxide
82. Decrements in spirometry values associated with chlorine gassing events and pulp mill work
83. Genetic risk factors for chronic obstructive pulmonary disease
84. Respiratory effects of chronic hydrogen sulfide exposure
85. Styrene and methyl methacrylate in the industrial environment as a risk factor of chronic obstructive lung disease
86. Pulmonary function defects in nonsmoking vinyl chloride workers
87. Lung function in insulation workers
88. Effects of air pollution and smoking on chronic obstructive pulmonary disease and bronchial asthma
89. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: Results from the APHEA project
90. Air pollution and hospital admissions for the elderly in Detroit, Michigan
91. Particulate air pollution and hospital emergency room visits for asthma in Seattle
92. Air pollution and hospital admissions for respiratory disease
93. Air pollution and hospital admission for respiratory causes in Minneapolis-St. Paul and Birmingham
94. Air pollution and hospital admissions in Sydney, Australia, 1990 to 1994
95. A longitudinal study of emergency room visits and air pollution for Prince George, British Columbia
96. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: A 5-year study
97. Air pollution and daily mortality: A review and meta analysis
98. Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: A quantitative summary of APHEA study results. Air Pollution and health: A European approach
99. 2 in eight areas of Switzerland. The SAPALDIA Team. Swiss Study of Air Pollution and Lung Diseases in Adults
100. Chronic obstructive pulmonary disease in two cities of contrasting air quality
101. Synergistic effects of air pollution and personal smoking on adult pulmonary function
102. Urban living, tobacco smoking, and chronic obstructive pulmonary disease: A study in Athens
103. The UCLA population studies of chronic obstructive respiratory disease. XI: Impact of air pollution and smoking on annual change in forced expiratory volume in one second
104. Passive smoking and chronic respiratory disease symptoms in non-smoking adults
105. Respiratory function and symptoms in urban office workers in relation to oxidant air pollution exposure
106. Lung function and chronic exposure to air pollution: A cross-sectional analysis of NHANES II
107. Effects of air pollution resulting from wire reclamation incineration on pulmonary function in children
108. Respiratory morbidity 10 years after the Union Carbide gas leak at Bhopal: A cross sectional survey. The International Medical Commission on Bhopal
109. Wood smoke exposure and risk for obstructive airways disease among women
110. Domestic smoke pollution and respiratory function in rural Nepal
111. Exposure to biomass smoke and chronic airway disease in Mexican women
112. Indoor biofuel air pollution and respiratory health: The role of confounding factors among women in highland Guatemala
113. Risk factors for chronic obstructive lung disease in Saudi Arabia
114. Dietary influences on chronic obstructive lung disease and asthma: A review of the epidemiological evidence
115. Dietary antioxidant vitamin intake and lung function in the general population
116. Cigarette smoke exposure of school children: Effect of passive smoking and vitamin E supplementation on blood antioxidant
117. Dietary determinants of long-term incidence of chronic nonspecific lung diseases
118. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease
119. Fish consumption may limit the damage of smoking on the lung
120. Alcohol consumption and airway obstruction
121. Alcohol consumption and chronic obstructive pulmonary disease
122. Retinoic and treatment abrogates elastase-induced pulmonary emphysema in rats
123. Assessment of vitamin A status in chronic obstructive disease patients and healthy smokers
124. A follow-up study of the natural history of obstructive bronchitis
125. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood
126. Familial aggregation of pulmonary function measurements
127. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity
128. Genetic and environmental determinants of chronic obstructive pulmonary disease
129. Genetic and environmental determinants of level of pulmonary function
130. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins
131. Major genetic mechanisms in pulmonary function
132. Heritability of ventilatory function in smoking and non-smoking New Mexico Hispanics
133. Segregation analysis of two lung function indices in a random sample of young families: The Humboldt Family Study
134. Segregation analysis of pulmonary function among families in the Framingham Study
135. Familial factors related to lung function in children aged 6-10 years
136. Genetic and environmental determinants of chronic obstructive pulmonary disease
137. Genetic-environmental interactions in chronic airways obstruction
138. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study
139. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease
140. Heterozygous alpha 1-antitrysin deficiency: A longitudinal lung function study
141. Molecular abnormality of human alpha 1-antitrypsin variant (Pi-ZZ). associated with plasma activity deficiency
142. Natural history and life expectancy in severe alpha 1-antitrypsin deficiency, Pi Z
143. 1 related to smoking status in individuals with severe alpha 1-antitrypsin deficiency
144. The prevalence of alpha-antitrypsin heterozygotes (PiMZ) in patients with obstructive pulmonary disease
145. Heterozygous and homozygous alpha-antitrypsin deficiency in patients with pulmonary emphysema
146. The PiMZ phenotype: Is it a significant risk factor for the development of chronic obstructive lung disease?
147. Pathophysiology of hereditary emphysema
148. The prevalence of alpha 1-antitrypsin deficiency in selected groups of patients with chronic obstructive lung disease
149. Liver, lung and malignant disease in heterozygous (PiMZ) alpha 1-antitrypsin deficiency
150. Collaborative study to assess risk of lung disease in Pi MZ phenotype
151. The genetics of asthma
152. Selection bias of PiMZ subjects
153. Lung distensibility and airway function in intermediate alpha 1-antitrypsin
154. Regulation of the alpha 1-antitrypsin gene and a disease-associated mutation in a related enhancer sequence
155. Mutation in an alpha 1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors
156. Alpha-1-antichymotrypsin is an effective inhibitor of pancreatitis induced lung injury
157. A 370-kb cosmid contig of the serpin gene cluster on human chromosome 14q32.1: Molecular linkage of the genes encoding alpha 1-antichymotrypsin, protein C inhibitor, kallistatin, alpha globulin
158. 1-antichymotrypsin allele associated with familial obstructive lung disease
159. DNA polymorphisms of the alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease
160. Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease
161. Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease
162. A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease
163. Detection of an alteration of the alpha 2-macroglobulin gene in a patient with chronic lung disease and serum alpha 2-macroglobulin deficiency
164. Genetic risk factors for chronic obstructive pulmonary disease
165. Genetics and pulmonary medicine. 9: Molecular genetics of chronic obstructive pulmonary disease
166. Requirement for macrophage elastase for cigarette smoking-induced emphysema in mice
167. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema
168. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema
169. Genetic markers in chronic air-flow limitation: A genetic epidemiologic study
170. Selective immunoglobulin A deficiency and chronic obstructive lung disease
171. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3
172. IgG subclass pattern in primary immunodeficiency disorders
173. IgG3 deficiency: Common in obstructive lung disease. Hereditary in families with immunodeficiency and autoimmune disease
174. Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease
175. Co-chemotactic effect of Gc-globulin (vitamin D binding protein) for C5a. Transient conversion into an active co-chemotaxin by neutrophils
176. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin
177. Gcglobulin functions as a cochemotaxin taxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers
178. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg
179. Possible protective effect against chronic obstructive airways disease by the Gc2 allele
180. Vitamin D binding protein variants and the risk of COPD
181. Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease
182. CD8(+) T cell subsets and chronic obstructive pulmonary disease
183. Differences and similarities between chronic obstructive pulmonary disease and asthma
184. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects
185. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors
186. The role of pulmonary surfactant in obstructive airways disease
187. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers
188. Risk factors associated with longitudinal change in pulmonary function
189. Is ABH nonsecretor status a risk factor for obstructive lung disease?
190. Risk factors in chronic obstructive pulmonary disease (COPD)
191. An index of risk for obstructive airways disease
192. Gyntelberg. Genetic markers for chronic bronchitis and peak expiratory flow in the Copenhagen Male Study
193. Lack of relationship between ABH secretor status and lung function in pulp mill workers
194. ABO, Lewis and secretor status and relative incidence of airflow obstruction
195. 1, wheezing, and asthma
196. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis
197. Chronic obstructive pulmonary diseaseis associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress
198. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
199. Chronic obstructive pulmonary disease: Risk factors, pathophysiology, and pathogenesis
200. Quantitative relationships between cigarette smoking and ventilatory function
201. Genetic-environmental interactions in chronic airways obstruction
202. ″Sensitive tests″ are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers
203. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis
204. Alpha-1-antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association
205. Pulmonary function associated with the Mmalton deficient variant of alpha 1-antitrypsin
206. Family study of alpha 1-antitrypsin deficiency: Effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits
207. Pulmonary function in Pi M and MZ grainworkers
208. Smoking and intermediate alpha 1-antitrypsin deficiency and lung function in middle aged men
209. Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease
210. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
211. Airways obstruction in patients with long-term asthma consistent with ″irrevesible asthma″
212. 1 in adults of a Norwegian community
213. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: The Normative Aging Study
214. 1 decline in older adults: The Normative Aging Study
215. Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease
216. Obstructive diseases: General principles and diagnostic approach
217. Airway inflammation and remodeling in asthma
218. High resolution computed tomography in asthma
219. Pseudophysiologic emphysema resulting from severe small-airways disease
220. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction
221. Single breath diffusing capacity for carbon monoxide in stable asthma
222. Single breath carbon monoxide transfer factor in different forms of chronic airflow obstruction in a general population sample
223. Carbon monoxide diffusing capacity in asthmatic patients with mild airflow limitation
224. Comparison of the components of diffusing capacity utilizing the effective alveolar volume in patients with emphysema and chronic asthma
225. Diffusion of gases within the lungs of patients with chronic obstructive pulmonary disease
226. Pseudophysiologic emphysema resulting from severe small-airways disease
227. Skin test reactivity to common aeroallergens and decline of lung function. The Normative Aging Study
228. The role of allergy and non-specific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease